Eyeglass frame allergic contact dermatitis: does tacrolimus prevent recurrences?

Authors: Nakada, Tokio1; Iijima, Masafumi1; Maibach, Howard I.2

Source: Contact Dermatitis, Volume 53, Number 4, October 2005 , pp. 219-221(3)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

A 35-year-old man developed well-demarcated, oedematous and erosive erythematous lesions on the nasal bridge and retroauricular regions bilaterally. His eyeglass frame was repaired by an optician 2 weeks prior to symptom onset. Patch testing revealed a positive reaction to scrapings of nose pads and temples of the frame in petrolatum. Because the patient did not take our exhortation to change eyeglass frames, we advised him to cover their nose pads and temples with vinyl tape to prevent direct skin contact. Although topical corticosteroid therapy produced clinical resolution temporally, recurrences were not prevented. After starting tacrolimus ointment therapy, recurrence has not occurred for 9 months. Tacrolimus may be effective for allergic contact dermatitis patients who cannot avoid repeated allergen exposure, as it may not only reduce inflammation but inhibit recurrences.

Keywords: allergic contact dermatitis; eyeglass frame; tacrolimus ointment

Document Type: Research article

DOI: 10.1111/j.0105-1873.2005.00664.x

Affiliations: 1: Department of Dermatology, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan, and 2: Department of Dermatology, University of California, San Francisco, CA, USA

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$44.84 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A